Clinical trial
Prevalence of Cannabidiol (CBD) Consumption and Cancer Patients' Expectations in One Oncology Day-Hospital: A Cross-sectional Study and Questionnaire Validation
NCT05407298 is registered in ClinicalTrials.gov with CHU de Reims as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevalence of Cannabidiol (CBD) Consumption and Cancer Patients' Expectations in One Oncology Day-Hospital: A Cross-sectional Study and Questionnaire Validation
- Lead sponsor
- CHU de Reims
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 15, 2021
- Completion date
- April 30, 2022
- Enrollment
- 350 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer